Histopathological examination is the gold standard for diagnosis, whereas elevated IL-10 or an IL-10/IL-6 ratio > 1 serves as a screening indicator for intraocular DLBCL. This evidence concerns the gene IL10 and diffuse large B-cell lymphoma.